Long‐term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapy-Reference-Cited by-同舟云学术

Long‐term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapy

Published:2018-09-06 Issue:1 Volume:63 Page:116-123
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imaging Radiat Oncol

Author:

Leon Jeremiah F¹^ORCID,Kneebone Andrew²³^ORCID,Gebski Val³⁴⁵,Cross Shamira⁵⁶^ORCID,Do Viet⁶⁷⁸,Hayden Amy⁵⁶,Ngo Diana⁷,Sidhom Mark⁷⁸,Turner Sandra³⁵^ORCID

Affiliation:

1. Department of Radiation Oncology Illawarra Cancer Care Centre Wollongong New South Wales Australia

2. Northern Sydney Cancer Centre Sydney New South Wales Australia

3. University of Sydney Sydney New South Wales Australia

4. NHMRC Clinical Trials Centre Sydney New South Wales Australia

5. Crown Princess Mary Cancer Centre Westmead Hospital Sydney New South Wales Australia

6. Nepean Cancer Centre Sydney New South Wales Australia

7. Liverpool and Macarthur Cancer Therapy Centre Sydney New South Wales Australia

8. University of New South Wales New South Wales Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.12797

Reference46 articles.

1. Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer

2. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

3. AJCC Cancer Staging Manual

4. NCCN.National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Prostate Cancer Version 2.2017. 2017 [Cited 2 August 2016.] Available from URL:https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.

5. Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer;Strahlentherapie und Onkologie;2021-08-05

2. Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects;Strahlentherapie und Onkologie;2020-07-08